Antigen-loaded ER microsomes from APC induce potent immune responses against viral infection

European Journal of Immunology

Volumn 39, Issue 1, 2009, Pages 85-95

  Sofra, Vassiliki ^a   Mansour, Salah ^a   Liu, Mengya ^b   Gao, Bin ^c   Primpidou, Elisavet ^b   Wang, Ping ^a   Li, Suling ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

DC; Microsome; T cells; Vaccination

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DENDRITIC CELL VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; PEPTIDE VACCINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; OVA 8; OVA-8; PEPTIDE FRAGMENT; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOPLASMIC RETICULUM; IMMUNE RESPONSE; IN VIVO STUDY; LYMPHOID ORGAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROSOME MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINIA VIRUS; VIRUS IMMUNITY; VIRUS INFECTION; ANIMAL; ANTIGEN PRESENTATION; C57BL MOUSE; CYTOLOGY; IMMUNOLOGY; MICROSOME; SPLEEN; TRANSGENIC MOUSE; ULTRASTRUCTURE; VACCINIA; VIROLOGY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSOMES; OVALBUMIN; PEPTIDE FRAGMENTS; SPLEEN; VACCINIA; VIRAL VACCINES; VIRUS DISEASES;

EID: 60549092742     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838443     Document Type: Article

References (31)

1. Yewdell, J. W. and Haeryfar, S. M., Understanding presentation of viral antigens to CD81T cells in vivo: The key to rational vaccine design. Annu. Rev. Immunol. 2005. 23: 651-682.
2. Liebowitz, D. N., Lee, K. P. and June, C. H., Costimulatory approaches to adoptive immunotherapy. Curr. Opin. Oncol. 1998. 10: 533-541.
3. Robinson, H. L. and Amara, R. R., T cell vaccines for microbial infections. Nat. Med. 2005. 11: S25-S32.
4. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
5. Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B. et al., Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002. 297: 1867-1870.
6. Lan, Y. Y., Wang, Z., Raimondi, G., Wu, W., Colvin, B. L., de Creus, A. and Thomson, A. W., Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J. Immunol. 2006. 177: 5868-5877.
7. Kobie, J. J., Wu, R. S., Kurt, R. A., Lou, S., Adelman, M. K., Whitesell, L. J., Ramanathapuram, L. V. et al., Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines. Cancer Res. 2003. 63: 1860-1864.
8. Kim, J. V., Latouche, J., Rivière, I. and Sadelain, M., The ABCs of artificial antigen presentation. Nat. Biotechnol. 2004. 22: 403-410.
9. Kovar, M., Boyman, O., Shen, X., Hwang, I., Kohler, R. and Sprent, J., Direct stimulation of T cells by membrane vesicles from antigen-presenting cells. Proc. Natl. Acad. Sci. USA 2006. 103: 11671-11676.
10. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P. et al., Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat. Med. 1998. 5: 594-600.
11. Kropshofer, H., Hämmerling, G. J., Vogt, A. B., The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules. Immunol. Rev. 1999. 172: 267-278. [Review].
12. Li, S., Paulsson, K. M., Sjogren, H. O. and Wang, P., Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing. J. Biol. Chem. 1999. 274: 8649-8654.
13. Mullins, D. W., Sheasley, S. L., Ream, R. M., Bullock, T. N., Fu, Y. X. and Engelhard, V. H., Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. J. Exp. Med. 2003. 198: 1023-1034.
14. Restifo, N. P., Bacik, I., Irvine, K. R., Yewdell, J. W., McCabe, B. J., Anderson, R. W., Eisenlohr, L. C. et al., Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 1995. 154: 4414-4422.
15. Osada, T., Clay, T. M., Woo, C. Y., Morse, M. A. and Lyerly, H. K., Dendritic cell based immunotherapy. Int. Rev. Immunol. 2006. 5: 377-413.
16. Nestle, F. O., Farkas, A. and Conrad, C., Dendritic-cell-based therapeutic vaccination against cancer. Curr. Opin. Immunol. 2005. 17: 163-169.
17. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003. 21: 685-711.
18. Martin-Fontecha, A., Sebastiani, S., Hopken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A. and Sallusto, F., Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. J. Exp. Med. 2003. 198: 615-621.
19. Liu, K., Waskow, C., Liu, X., Yao, K., Hoh, J. and Nussenzweig, M., Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 2007. 8: 578-583.
20. Cyster, J. G. and Goodnow, C. C., Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J. Exp. Med. 1995. 182: 581-586.
21. Weninger, W., Crowley, M. A., Manjunath, N. and von Andrian, U. H., Migratory properties of naive, effector, and memory CD8(+) T cells. J. Exp. Med. 2001. 194: 953-966.
22. Hammerling, G. J. and Moreno, J., The function of the invariant chain in antigen presentation by MHC class II molecules. Immunol. Today 1990. 11: 337-340.
23. Smits, H. H., de Jong, E. C., Wierenga, E. A. and Kapsenberg, M. L., Different faces of regulatory DCs in homeostasis and immunity. Trends Immunol. 2005. 26: 123-129.
24. Szeberenyi, J. B., Rothe, G., Pallinger, E., Orso, E., Falus, A. and Schmitz, G., Multicolor analysis of monocyte and dendritic cell precursor heterogeneity in whole blood. Immunobiology 2000. 202: 51-58.
25. Taieb, J., Chaput, N. and Zitvogel, L., Dendritic cell-derived exosomes as cell-free peptide-based vaccines. Crit. Rev. Immunol. 2005. 25: 215-223.
26. Chaput, N., Schartz, N. E., Andre, F., Taieb, J., Novault, S., Bonnaventure, P., Aubert, N. et al., Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol. 2004. 172: 2137-2146.
27. Stoorvogel, W., Kleijmeer, M. J., Geuze, H. J. and Raposo, G., The biogenesis and functions of exosomes. Traffic 2002. 3: 321-330.
28. Enk, A. H., Jonuleit, H., Saloga, J. and Knop, J., Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int. J. Cancer 1997. 73: 309-316.
29. Aloman, C., Gehring, S., Wintermeyer, P., Kuzushita, N. and Wands, J. R., Chronic ethanol consumption impairs cellular immune responses against HCV NS5 protein due to dendritic cell dysfunction. Gastroenterology 2007. 132: 698-708.
30. Wang, P., Gyllner, G. and Kvist, S., Selection and binding of peptides to human transporters associated with antigen processing and rat cim-a and -b. J. Immunol. 1996. 157: 213-220.
31. Kinney, B. R. M., Esposito, J. J., Mathews, J. H., Johnson, B. J., Roehrig, J. T., Barrett, A. D. and Trent, D. W., Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J. Virol. 1988. 62: 4697-4702.